Cited by 43Cancer, Hypoxia, and MetabolismRenal cell carcinoma treatmentCancer Genomics and Diagnostics

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma

Open access
Xu, Jianing, Reznik, Ed, Lee, Ho-Joon, Gundem, Gunes, Jonsson, Philip, Sarungbam, Judy, Bialik, Anna, Sanchez-Vega, Francisco +25 more·2019·eLife

Abstract

While genomic sequencing routinely identifies oncogenic alterations for the majority of cancers, many tumors harbor no discernable driver lesion. Here, we describe the exceptional molecular phenotype of a genomically quiet kidney tumor, clear cell papillary renal cell carcinoma (CCPAP). In spite of a largely wild-type nuclear genome, CCPAP tumors exhibit severe depletion of mitochondrial DNA (mtDNA) and RNA and high levels of oxidative stress, reflecting a shift away from respiratory metabolism. Moreover, CCPAP tumors exhibit a distinct metabolic phenotype uniquely characterized by accumulation of the sugar alcohol sorbitol. Immunohistochemical staining of primary CCPAP tumor specimens recapitulates both the depletion of mtDNA-encoded proteins and a lipid-depleted metabolic phenotype, suggesting that the cytoplasmic clarity in CCPAP is primarily related to the presence of glycogen. These results argue for non-genetic profiling as a tool for the study of cancers of unknown driver.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.38986

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Detailed molecular analysis of CCPAP found a low genomic burden of point mutations and copy-number variants, no recurrent nonsynonymous mutations, and a DNA methylation pattern resembling nonmalignant kidney.

    “Nevertheless, a detailed molecular analysis revealed a low genomic burden of point mutations and copy-number variants, no recurrent nonsynonymous mutations, and a DNA methylation pattern that resembles the nonmalignant kidney.”

    From Metabolic reprogramming and cancer progression (2020) · cites this paper as [13]

  • CCPAP tumors have metabolomic signatures suggesting oxidative stress, suppressed oxidative metabolism, and depletion of mitochondrial DNA and RNA.

    “These tumors bear metabolomic signatures that suggest oxidative stress, suppressed oxidative metabolism, and depletion of mitochondrial DNA and RNA.”

    From Metabolic reprogramming and cancer progression (2020) · cites this paper as [13]

  • Some tumors lack recurrent mutations in canonical tumor suppressors and oncogenes but still have stereotyped metabolic properties that distinguish them from nonmalignant tissues.

    “Some tumors lack recurrent mutations in canonical tumor suppressors and oncogenes but still harbor stereotyped metabolic properties that distinguish them from nonmalignant tissues.”

    From Metabolic reprogramming and cancer progression (2020) · cites this paper as [13]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Masson P 1929 Some histological methods: trichrome stainings and their preliminary technique Journal of Technical Methods 12 75 90

Cited by

Sorted by citations

Authors
Xu, J., Reznik, E., Lee, H.-J., Gundem, G., Jonsson, P., Sarungbam, J., Bialik, A., Sanchez-Vega, F., Creighton, C. J., Hoekstra, J., Zhang, L., Sajjakulnukit, P., Kremer, D., Tolstyka, Z., Casuscelli, J., Stirdivant, S., Tang, J., Schultz, N., Jeng, P., Dong, Y., Su, W., Cheng, E. H., Russo, P., Coleman, J. A., Papaemmanuil, E., Chen, Y.-B., Reuter, V. E., Sander, C., Kennedy, S. R., Hsieh, J. J., Lyssiotis, C. A., Tickoo, S. K., & Hakimi, A. A.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • University of Michigan (US)
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, United States
  • Baylor College of Medicine (US)
  • University of Washington (US)
  • Ludwig-Maximilians-Universität München (DE)
  • Metabolon Inc, Durham, United States
  • Cedars-Sinai Medical Center (US)
  • Harvard University (US)
  • Washington University in St. Louis (US)
Corresponding author
  • Reznik, Ed
  • Lyssiotis, Costas A
  • Tickoo, Satish K
  • Hakimi, A Ari
Venue
eLife
Published
2019-04-01
Volume
8
ISSN
2050-084X (ISSN-L)
OpenAlex
W2933385111
Cited by
43
References
56
Citations by year
2026: 3 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 11 · 2020: 10 · 2019: 4
FWCI
2.29
Type
journal article
Language
en
Open access
Locations
  • eLife (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion, cc-by)
Funders
  • Damon Runyon Cancer Research Foundation (Dale F. Frey Award for Breakthrough Scientists, DFS-09-14)
  • V Foundation for Cancer Research (Junior Scholar Award, V2016-009)
  • Sidney Kimmel Foundation for Cancer Research (Kimmel Scholar Award, SKF-16-005)
  • National Institutes of Health (DK097153)
  • Charles Woodson Research Fund
  • The UM Pediatric Brain Tumor Initiative
  • University of Michigan (Program in Chemical Biology - Graduate Assistance in Areas of National Need (GAANN) award)
  • National Cancer Institute (P30 CA008748, P30 CA046592)
  • American Urological Association (Research Scholar Award)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal cell carcinoma treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
clear cell papillary renal cell carcinoma, oxidative stress, mitochondrial DNA depletion, mitochondrial dysfunction, respiratory metabolism, sorbitol accumulation, glycogen, lipid depletion, cancer metabolism
MeSH terms
Aerobiosis, Carcinoma, Renal Cell, Histocytochemistry, Humans, Immunohistochemistry, Kidney Neoplasms, Oxidation-Reduction, Cell Respiration, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review